45 results on '"Hales, Chadwick M."'
Search Results
2. Integration of plasma and CSF metabolomics with CSF proteomic reveals novel associations between lipid mediators and central nervous system vascular and energy metabolism
3. Transcobalamin Receptor Autoantibodies in Central Vitamin B12 Deficiency
4. Literature-Based Discovery Predicts Antihistamines Are a Promising Repurposed Adjuvant Therapy for Parkinson’s Disease
5. A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment
6. Glial profiling of human tauopathy brain demonstrates enrichment of astrocytic transcripts in tau-related frontotemporal degeneration
7. The Georgia Memory Net: Implementation of a statewide program to diagnose and treat Alzheimer's disease and related dementias
8. A Phase II Study Repurposing Atomoxetine for Neuroprotection in Mild Cognitive Impairment
9. A proteomic network approach resolves stage-specific molecular phenotypes in chronic traumatic encephalopathy
10. 5-hydroxymethylcytosine is dynamically regulated during forebrain organoid development and aberrantly altered in Alzheimer’s disease
11. Cell-type-specific profiling of human cellular models of fragile X syndrome reveal PI3K-dependent defects in translation and neurogenesis
12. Urokinase-type plasminogen activator promotes N-cadherin-mediated synaptic recovery in the ischemic brain
13. Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase and ethanolamides metabolism with Alzheimer’s disease
14. Chimeric Peptide Species Contribute to Divergent Dipeptide Repeat Pathology in c9ALS/FTD and SCA36
15. CRISPR-mediated gene correction links the ATP7A M1311V mutations with amyotrophic lateral sclerosis pathogenesis in one individual
16. Rab11 Interacting Proteins as Regulators of Parietal Cell Apical Recycling: Lessons from the Master
17. O4-11-05: A PROOF OF CONCEPT PHASE II STUDY REPURPOSING ATOMOXETINE FOR NEUROPROTECTION IN MILD COGNITIVE IMPAIRMENT: EVIDENCE FOR TARGET ENGAGEMENT, REGULATION OF CSF BIOMARKERS, AND DISEASE-MODIFYING POTENTIAL
18. TDP-43 cytoplasmic inclusion formation is disrupted in C9orf72-associated amyotrophic lateral sclerosis/frontotemporal lobar degeneration
19. Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer’s disease-related proteins
20. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD
21. Characterization of Detergent Insoluble Proteome in Chronic Traumatic Encephalopathy
22. Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients
23. A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer’s Disease
24. Changes in the detergent-insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression
25. Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementia
26. Abstract WP429: The Cognitive Impairment in Stroke Screener (CISS) Tool: an Improved Screening Tool to Detect Cognitive Impairment Early Among Stroke Patients
27. A human pluripotent stem cell model of catecholaminergic polymorphic ventricular tachycardia recapitulates patient-specific drug responses
28. Aggregation Properties of the Small Nuclear Ribonucleoprotein U1-70K in Alzheimer Disease
29. Integrated Approaches for Analyzing U1-70K Cleavage in Alzheimer’s Disease
30. U1 small nuclear ribonucleoproteins (snRNPs) aggregate in Alzheimer’s disease due to autosomal dominant genetic mutations and trisomy 21
31. Aggregates of Small Nuclear Ribonucleic Acids (snRNAs) in Alzheimer's Disease
32. Abnormal Gephyrin Immunoreactivity Associated With Alzheimer Disease Pathologic Changes
33. U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer’s disease
34. Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration
35. From frontotemporal lobar degeneration pathology to frontotemporal lobar degeneration biomarkers
36. Stimulus-evoked high frequency oscillations are present in neuronal networks on microelectrode arrays
37. How to Culture, Record and Stimulate Neuronal Networks on Micro-electrode Arrays (MEAs)
38. How to Culture, Record and Stimulate Neuronal Networks on Micro-electrode Arrays (MEAs)
39. MARK2/EMK1/Par-1Bα Phosphorylation of Rab11-Family Interacting Protein 2 Is Necessary for the Timely Establishment of Polarity in Madin-Darby Canine Kidney Cells
40. Dynamics of the Apical Plasma Membrane Recycling System During Cell Division
41. Rab11 Family Interacting Protein 2 Associates with Myosin Vb and Regulates Plasma Membrane Recycling
42. Identification and Characterization of a Family of Rab11-interacting Proteins
43. Direct Interaction of the Spinal Muscular Atrophy Disease Protein SMN with the Small Nucleolar RNA-associated Protein Fibrillarin
44. Myosin Vb Is Associated with Plasma Membrane Recycling Systems
45. Rab11a-FIP1 and Rab11a-FIP2 translocate to the secretory canaliculus of parietal cells upon stimulation with histamine
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.